PLXP PLx Pharma Inc.

4.74
-0.24  -5%
Previous Close 4.98
Open 5.42
Price To Book 12.15
Market Cap 41471080
Shares 8,749,173
Volume 11,974
Short Ratio
Av. Daily Volume 67,439

SEC filingsSee all SEC filings

  1. 8-K - Current report 19619486
  2. 8-K - Current report 19604003
  3. DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material 19598647
  4. DEF 14A - Other definitive proxy statements 19520321
  5. 8-K - Current report 19512287

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 top-line data did not meet endpoints - October 25, 2016.
Locilex
Mild infections of diabetic foot ulcers
sNDA filing for 81mg dose has been delayed - noted March 23, 2018. To be filed late likely late 2019.
Aspertec
Aspirin - cardiovascular and stroke patients patients

SEC Filings

  1. 8-K - Current report 19619486
  2. 8-K - Current report 19604003
  3. DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material 19598647
  4. DEF 14A - Other definitive proxy statements 19520321
  5. 8-K - Current report 19512287
  6. SC 13D/A [Amend] - General statement of acquisition of beneficial ownership 181260132
  7. PRE 14A - Other preliminary proxy statements 181253032
  8. 8-K - Current report 181249324
  9. 10-Q - Quarterly report [Sections 13 or 15(d)] 181171425
  10. 8-K - Current report 181077877